Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jonathan Piccini MD, MHS, FACC, FAHA, FHRS

Jonathan P. Piccini MD, MHS, FACC, FAHA, FHRS

Professor of Medicine & Population Health, Director of Cardiac Electrophysiology, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina

Jonathan P. Piccini, MD, MHS, FACC, FAHA, FHRS, is a clinical cardiac electrophysiologist and Professor of Medicine at Duke University Medical Center and the Duke Clinical Research Institute. He is the Director of the Cardiac Electrophysiology section at the Duke Heart Center. His focus is on the care of patients with atrial fibrillation and complex arrhythmias, with particular emphasis on catheter ablation and lead extraction. His research interests include the development and evaluation of innovative cardiovascular interventions for the treatment of heart rhythm disorders. He serves on the Board of Trustees of the Heart Rhythm Society, is an Associate Editor at JACC: Clinical Electrophysiology, and is an elected member of the American Society for Clinical Investigation. Dr. Piccini has more than 550 publications in the field of heart rhythm medicine and has been the recipient of several teaching and mentorship awards.

Disclosures

Dr. Piccini has received research grants for clinical research from Abbott, ARCA biopharma, Boston Scientific, Gilead, Janssen Pharmaceuticals, and Phillips and serves as a consultant to Allergan, Bayer, Johnson & Johnson, Medtronic, Sanofi, and Phillips.

Recent Contributions to PracticeUpdate:

  1. ICD Shocks in Patients With LVADs: Prevalence, Associated Factors, and Etiologies
  2. Inhibition of the KCa2 Potassium Channel in Atrial Fibrillation
  3. Left Atrial Appendage Occlusion vs Oral Anticoagulation in Atrial Fibrillation
  4. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial
  5. Long-Term Outcomes Associated With ICDs in Adults With Chronic Kidney Disease

Most Read This Week

Recently Updated